NEW YORK (GenomeWeb) – GenMark Diagnostics reported on Tuesday that it expects fourth quarter revenues of $14.9 million, up 13 percent year over year.

The company also reported preliminary full-year 2016 revenues of $49.2 million, up 25 percent compared to 2016.

The preliminary revenues just beat the average Wall Street estimate of $14.8 million for Q4 and $49.1 million for 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.